Book is a practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results
An earlier book, A Strategic Approach to Corporate Governance (Gower, 1999), examined corporate governance from a philosophical and 'big picture' standpoint.
This book digs deeper and explores the operational issues around corporate governance, giving examples of good practice.
It is a 'how to' book, which focuses on processes and practical issues.
The problem is that pharmaceutical businesses are complex.
Drug research and development involves extended and expensive processes; defining appropriate metrics for these processes is not easy, yet ineffective or misguided metrics can be more damaging than none at all.
David Zuckerman's Pharmaceutical Metrics is an extremely practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results.
And because metrics are about how to shape and develop your business, he explores how to deploy them organisation-wide and make sure that they are driving business improvement.
In order to reflect the needs of different types of pharmaceutical company the author uses four sample companies, throughout the book, to illustrate the principles for 'big pharma', 'micro pharma', a virtual development company and a CRO.
This highly practical book provides a step-by-step guide to creating a state-of-the-art, strategy-driven metrics system for pharmaceutical R+D, supported by case studies of the techniques applied and tips for optimizing the system.
Pharmaceutical Metrics (0 566 08676 X) by David S Zuckerman has just been published by Gower.
It is available in hardback priced at £75.00.
